Kevin Waters Biography and Net Worth

EVP, CFO of PROCEPT BioRobotics

Mr. Waters has served as our EVP, Chief Financial Officer since January 2022. He previously served as our SVP, Chief Financial Officer from October 2018 until December 2021. Prior to joining PROCEPT BioRobotics Mr. Waters served as Chief Financial Officer at Accuray Inc., a radiation oncology company, from September 2015 to October 2018. In addition to his experience at Accuray, Inc., Mr. Waters held financial leadership positions at three publicly traded medical device companies, including Conceptus, Laserscope and VISX. These companies were all sold to strategic acquirers, generating approximately $3 billion in shareholder value. Mr. Waters began his career at PricewaterhouseCoopers, LLP. and received a B.S. in Business Administration, with a double concentration in Accounting and Finance from Cal Poly San Luis Obispo

What is Kevin Waters' net worth?: The estimated net worth of Kevin Waters is at least $3.52 million as of March 17th, 2026. Mr. Waters owns 151,558 shares of PROCEPT BioRobotics stock worth more than $3,516,146 as of April 11th. This net worth approximation does not reflect any other investments that Mr. Waters may own. Learn More about Kevin Waters' net worth.
How do I contact Kevin Waters?: The corporate mailing address for Mr. Waters and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Kevin Waters' contact information.
Has Kevin Waters been buying or selling shares of PROCEPT BioRobotics?: Kevin Waters has not been actively trading shares of PROCEPT BioRobotics within the last three months. Most recently, Kevin Waters sold 706 shares of the business's stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $28.15, for a transaction totalling $19,873.90. Following the completion of the sale, the executive vice president now directly owns 151,558 shares of the company's stock, valued at $4,266,357.70. Learn More on Kevin Waters' trading history.
Who are PROCEPT BioRobotics' active insiders?: PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Alaleh Nouri (EVP), Hisham Shiblaq (EVP, Chief Commercial Officer), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.
Are insiders buying or selling shares of PROCEPT BioRobotics?: In the last twelve months, PROCEPT BioRobotics insiders bought shares 3 times. They purchased a total of 426,262 shares worth more than $10,483,091.16. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 123,229 shares worth more than $6,844,716.03. The most recent insider tranaction occured on March, 19th when EVP Alaleh Nouri sold 5,363 shares worth more than $139,223.48. Insiders at PROCEPT BioRobotics own 6.6% of the company. Learn More about insider trades at PROCEPT BioRobotics.
Information on this page was last updated on 3/19/2026.

Kevin Waters Insider Trading History at PROCEPT BioRobotics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2026	Sell	706	$28.15	$19,873.90	151,558
3/6/2026	Sell	6,721	$23.70	$159,287.70	152,264
3/18/2025	Sell	733	$57.06	$41,824.98	107,991
10/15/2024	Sell	25,000	$72.47	$1,811,750.00	96,096
9/16/2024	Sell	25,000	$82.51	$2,062,750.00	96,096
3/18/2024	Sell	1,024	$48.83	$50,001.92	102,149
3/6/2024	Sell	3,435	$46.67	$160,311.45	49,416
2/12/2024	Sell	22,349	$50.16	$1,121,025.84	33,523
2/9/2024	Sell	28,677	$50.09	$1,436,430.93	33,523
2/7/2024	Sell	904	$50.00	$45,200.00	33,523
1/9/2024	Sell	17,310	$45.07	$780,161.70	33,523
12/13/2023	Sell	71,465	$40.05	$2,862,173.25	33,523
12/8/2023	Sell	6,888	$40.02	$275,657.76	33,523
12/6/2023	Sell	4,360	$40.02	$174,487.20	44,248
6/15/2023	Sell	22,631	$35.12	$794,800.72	33,523
3/16/2023	Sell	706	$31.84	$22,479.04	56,154
3/7/2023	Sell	7,954	$34.25	$272,424.50	56,860

Kevin Waters Buying and Selling Activity at PROCEPT BioRobotics

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Today's Range

Now: $23.20

$22.81

$23.80

50 Day Range

MA: $26.32

$22.69

$29.95

2 Week Range

Now: $23.20

$19.35

$66.85

Volume

1,129,775 shs

Average Volume

1,256,558 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94